rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-2-8
|
pubmed:abstractText |
(1) To validate a previously reported risk index for predicting total serum bilirubin (TSB) levels of 25 mg/dL (428 micromol/L) or higher; (2) to combine a subset of this index with TSB levels measured at less than 48 hours to predict subsequent TSB levels of 20 mg/dL (342 micromol/L) or higher.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1072-4710
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
159
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15699303-Bilirubin,
pubmed-meshheading:15699303-Case-Control Studies,
pubmed-meshheading:15699303-Cohort Studies,
pubmed-meshheading:15699303-Female,
pubmed-meshheading:15699303-Humans,
pubmed-meshheading:15699303-Infant, Newborn,
pubmed-meshheading:15699303-Jaundice, Neonatal,
pubmed-meshheading:15699303-Male,
pubmed-meshheading:15699303-Predictive Value of Tests,
pubmed-meshheading:15699303-ROC Curve,
pubmed-meshheading:15699303-Retrospective Studies,
pubmed-meshheading:15699303-Risk Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns.
|
pubmed:affiliation |
Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco, CA 94143, USA. newman@itsa.ucsf.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Validation Studies
|